Back to Portfolio
3D PrintingImplantsAI DesignNeurosurgery
Founded
2019
Headquarters
Turku, Finland
Sector
MedTech
About
Ambrocio develops patient-specific medical implants using additive manufacturing, combining PEEK materials with FDA-approved Bioactive Glass S53P4 for cranio-maxillofacial reconstruction and bone regeneration. The company also provides AI-assisted software for automatic implant design and point-of-care manufacturing solutions, supported by patents in Finland, the US, and Europe.